RS Research
PrivateLast Round
Series A
Dec 15, 2021
Total Funding Raised
$14.16M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
RS Research operates in Healthcare & Life Sciences and is based in Turkey. Its latest recorded funding round was a Series A round in December 2021.
RS Research is a drug discovery company that develops targeted oncology therapies using its proprietary drug-delivery platforms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RS Research Comparables
Compare RS Research with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cybrexa Therapeutics | 82% | |
| OncoNano Medicine | 79% | |
| Avacta Group | 77% |
For institutional investors. Book with your work email.
RS Research Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 15, 2021 | ||||
| Seed | Apr 21, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
RS Research Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Eczacıbaşı Momentum | Series A |
| ACT Venture Partners | Series A, Seed |
| İstanbul Portföy Yönetimi | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors grew 107% MoM.
- Jul 20, 2026
Open roles increased from 0 to 8, representing 28% of headcount.
For institutional investors. Book with your work email.
RS Research Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about RS Research's valuation, stock price, and market status.
Is RS Research a public or private company?
RS Research is a private company.
What is the current stock price of RS Research?
RS Research is a private company, so its shares have no public market price. Caplight tracks RS Research's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RS Research worth (valuation)?
Valuation information for RS Research is not publicly available.
Can I buy RS Research stock?
RS Research shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RS Research's last funding round?
RS Research's most recent funding round was Series A on December 15, 2021.
Who are the main investors in RS Research?
Key investors in RS Research include Eczacıbaşı Momentum, ACT Venture Partners, İstanbul Portföy Yönetimi.
Will RS Research IPO soon?
No public IPO plans have been announced for RS Research.
How can I track RS Research secondary market activity?
Caplight tracks bids, offers, and trades in RS Research's shares on secondary markets.